BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
113.12
+20.37 (21.96%)
At close: Aug 19, 2026, 4:00 PM EDT
110.61
-2.51 (-2.22%)
Pre-market: Aug 20, 2026, 5:01 AM EDT
BioNTech SE Employees
BioNTech SE had 7,807 employees as of December 31, 2025. The number of employees increased by 1,035 or 15.28% compared to the previous year.
Employees
7,807
Change (1Y)
1,035
Growth (1Y)
15.28%
Revenue / Employee
$387,797
Profits / Employee
-$246,785
Market Cap
28.42B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7,807 | 1,035 | 15.28% |
| Dec 31, 2024 | 6,772 | 639 | 10.42% |
| Dec 31, 2023 | 6,133 | 1,603 | 35.39% |
| Dec 31, 2022 | 4,530 | 1,448 | 46.98% |
| Dec 31, 2021 | 3,082 | 1,141 | 58.78% |
| Dec 31, 2020 | 1,941 | 631 | 48.17% |
| Dec 31, 2019 | 1,310 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Moderna | 4,700 |
| Genmab | 3,119 |
| Jazz Pharmaceuticals | 2,890 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| Insmed | 1,664 |
| Ascendis Pharma | 1,189 |
| Exelixis | 1,077 |
BNTX News
- 15 days ago - BioNTech SE Earnings Call Transcript: Q2 2026 - Transcripts
- 15 days ago - BioNTech SE Earnings release: Q2 2026 - Filings
- 15 days ago - BioNTech SE Slides: Q2 2026 - Filings
- 15 days ago - Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings - Barrons
- 15 days ago - BioNTech lowers 2026 sales outlook as COVID vaccine demand softens - Reuters
- 15 days ago - BioNTech Announces Second Quarter 2026 Financial Results and Corporate Update - GlobeNewsWire
- 16 days ago - BioNTech says Sobi's Oelkers will replace Sahin as CEO - Reuters
- 17 days ago - BioNTech Announces Appointment of Guido Oelkers to Management Board as Chief Executive Officer - GlobeNewsWire